REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $240,000 | -61.4% | 52,495 | -41.9% | 0.02% | -61.9% |
Q2 2021 | $621,000 | -3.4% | 90,333 | +2.8% | 0.06% | -16.0% |
Q1 2021 | $643,000 | +2.4% | 87,837 | +13.0% | 0.08% | -2.6% |
Q4 2020 | $628,000 | +4.7% | 77,714 | +32.5% | 0.08% | -18.1% |
Q3 2020 | $600,000 | – | 58,664 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 444,301 | $2,284,000 | 1.33% |
683 Capital Management, LLC | 999,232 | $5,136,000 | 0.43% |
DAFNA Capital Management LLC | 35,000 | $180,000 | 0.10% |
MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $2,164,000 | 0.08% |
Migdal Insurance & Financial Holdings Ltd. | 397,324 | $2,042,000 | 0.05% |
Claret Asset Management Corp | 42,522 | $219,000 | 0.05% |
Orbimed Advisors | 564,900 | $2,904,000 | 0.04% |
Altshuler Shaham Ltd | 169,446 | $251,000 | 0.04% |
Virtu Financial LLC | 60,787 | $312,000 | 0.02% |
MEITAV INVESTMENT HOUSE LTD | 48,000 | $244,000 | 0.01% |